
BTI · NYSE
Consensus is Buy across nine analysts, with a stated mean price target of $68.50. The supplied consensus provides neither a low nor a high target, so the target cluster and spread cannot be measured. No analyst names are supplied, preventing identification of the most or least bullish contributors. The evidence also contains no rating changes, target revisions, or dated analyst commentary during the past week, so the direction of revisions is unavailable. The substantive disagreement behind the target range likewise cannot be established from the material provided. The available evidence supports a broadly positive consensus, but it does not explain whether that view rests primarily on U.S. nicotine growth, Velo’s modern oral momentum, valuation, income, or expectations for future performance.
